Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Footnotes Print ad full page + 1/3
-
Hi there, this question is related to a HCP printed ad, size full page and 1/3 (full page and column)
Based on the guidelines is it allowed to place footnotes in the 1/3 (column) portion of the ad? in this case, footnotes include: Indication
& Study design detailsThank you for the help!
-
Hello @joao-borges
Yes, you are allowed to place the footnotes on the 1/3 portion if presented side-by-side and clearly part of the same ad. If the column exists somewhere else in the journal or looks distinctly separate from the rest of the ad, the footnotes may not be allowed to be relegated to that space. As a courtesy, please note that indications should never appear as a footnote. It should always appear in the body copy (s2.10.1).
-
@jennifer-carroll thank you Jennifer!
